Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NC-NDPediatric pulmonology

Assessing the Effects of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis Outcomes: Insights From A Two‐Season Analysis

  • Marta Agüera1
  • Aleix Soler‐Garcia1
  • Sara Castellà1
  • Sara Moussalam‐Merino1
  • Carme Alejandre1
  • Daniel Penela‐Sánchez2
  • Cristina Esteva3
  • Clàudia Fortuny2
  • Mariona Fernández de Sevilla1
  • Juan‐José García‐García1
  • Iolanda Jordan2
  • Carmen Muñoz‐Almagro2
1 more authors
  • Cristian Launes1
  1. 1Hospital Sant Joan de Déu
  2. 2Institut de Recerca Sant Joan de Déu
  3. 3Universitat de Barcelona
Read full textPDFCite

Related

  1. Uptake of Respiratory Syncytial Virus Prefusion F Protein Vaccination during Pregnancy and nirsevimab among Infants over Two Seasons in a Single Health System.
    Jessica E Kerr, Annaliese J Calzadilla, Hui Liu +1
    Journal of pediatrics. Clinical practicePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  2. Maternal Vaccination vs Nirsevimab Use and Respiratory Syncytial Virus Infection Among Full-Term Infants
    Karen B. Jacobson, Andrew J. Watson, Lauren D. Liao +4
    JAMA Network OpenPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthCrossrefEurope PMC
  3. Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France
    Slim Fourati, Alawiya Reslan, Jérôme Bourret +97
    The Lancet MicrobePeer-reviewedCC BY-NC13 citedEpidemiology & public healthOpenAlex
  4. Effectiveness of nirsevimab against hospitalization for RSV bronchiolitis according to RSV lineages
    M. Barbier, C. Levy, R. Cohen +17
    medRxivPreprintAll rights reservedFull textObstetrics, gynaecology & paediatricsmedRxiv
  5. Weaning with meaning: optimising respiratory support de-escalation to improve outcomes in critically ill children with bronchiolitis
    Craig Pymento, Katherine Taylor, Mark Riccioni +3
    BMJ Open QualityPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC

Cite

BibTeXRIS
BibTeX
@article{aguera2026assessing,
  title = {{Assessing the Effects of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis Outcomes: Insights From A Two‐Season Analysis}},
  author = {Marta Agüera and Aleix Soler‐Garcia and Sara Castellà and Sara Moussalam‐Merino and Carme Alejandre and Daniel Penela‐Sánchez and Cristina Esteva and Clàudia Fortuny and Mariona Fernández de Sevilla and Juan‐José García‐García and Iolanda Jordan and Carmen Muñoz‐Almagro and Cristian Launes},
  journal = {Pediatric pulmonology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13662497},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Assessing the Effects of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis Outcomes: Insights From A Two‐Season Analysis
AU  - Marta Agüera
AU  - Aleix Soler‐Garcia
AU  - Sara Castellà
AU  - Sara Moussalam‐Merino
AU  - Carme Alejandre
AU  - Daniel Penela‐Sánchez
AU  - Cristina Esteva
AU  - Clàudia Fortuny
AU  - Mariona Fernández de Sevilla
AU  - Juan‐José García‐García
AU  - Iolanda Jordan
AU  - Carmen Muñoz‐Almagro
AU  - Cristian Launes
PY  - 2026
DA  - 2026/10/01
JO  - Pediatric pulmonology
UR  - https://europepmc.org/article/PMC/PMC13662497
SN  - 8755-6863
SN  - 1099-0496
ER  -